' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

MAYR CHRISTIAN REINHARD
Universitätsklinik für Innere Medizin 1 - Gastroenterologie- Hepatologie, Nephrologie, Stoffwechsel und Diabetologie
Universitätsinstitut für Physiologie und Pathophysiologie

Publikationen | Forscherprofil

69 Publikationen

2020

Beiträge in Fachzeitschriften

Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.
Bekric, D; Neureiter, D; Ritter, M; Jakab, M; Gaisberger, M; Pichler, M; Kiesslich, T; Mayr, C;
J Clin Med. 2020; 9(4):
Übersichtsarbeiten
How do we choose the appropriate chemotherapeutic agents for biliary tract cancer?
Neureiter, D; Mayr, C; Kiesslich, T;
Expert Opin Pharmacother. 2020; 21(3):243-245
Editorials
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.
Neureiter, D; Mayr, C; Winkelmann, P; Neumayer, B; Klieser, E; Wagner, A; Hufnagl, C; Emmanuel, K; Holzinger, J; Koch, O; Kiesslich, T; Varga, M;
Cells. 2020; 9(2):
Originalarbeiten (Zeitschrift)

2019

Beiträge in Fachzeitschriften

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.
Beyreis, M; Gaisberger, M; Jakab, M; Neureiter, D; Helm, K; Ritter, M; Kiesslich, T; Mayr, C;
Cancers (Basel). 2019; 11(3):
Originalarbeiten (Zeitschrift)
NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
Kiesslich, T; Mayr, C; Neureiter, D;
EBioMedicine. 2019; 49:9-10
Originalarbeiten (Zeitschrift)
Acid- and Volume-Sensitive Chloride Currents in Microglial Cells.
Kittl, M; Helm, K; Beyreis, M; Mayr, C; Gaisberger, M; Winklmayr, M; Ritter, M; Jakab, M;
Int J Mol Sci. 2019; 20(14):
Originalarbeiten (Zeitschrift)
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.
Klieser, E; Mayr, C; Kiesslich, T; Wissniowski, T; Fazio, PD; Neureiter, D; Ocker, M;
Int J Mol Sci. 2019; 20(21):
Übersichtsarbeiten
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Fuchs, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T;
Cell Adh Migr. 2019; 13(1):76-82
Originalarbeiten (Zeitschrift)
Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi, F; Stättner, S; Schlick, K; Kiesslich, T; Mayr, C; Klieser, E; Urbas, R; Neureiter, D;
Onco Targets Ther. 2019; 12: 3387-3400.
Übersichtsarbeiten

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

The cancer stem cell inhibitor napabucasin (BBI608) shows general cytotoxicity in biliary tract cancer cells and reduces cancer stem cell characteristics
Beyreis, M; Gaisberger, Martin; Jakab, M; Neureiter, D; Helm, K; Ritter, M; Kiesslich, T; Mayr, C;
7th Symposium of the Young Physiologists and Pharmacologists; 14.-15.03.2019; Nürnberg. 2019.
The cancer stem cell inhibitor napabucasin (BBI608) shows general cytotoxicity in biliary tract cancer cells and reduces cancer stem cell characteristics
Beyreis,M; Gaisberger, M; Jakab, M; Neureiter, D; Helm,K; Ritter, M; Kiesslich, T; Mayr, C;
PMU Science Get Together 2019; 28.06.2019; Nürnberg. 2019.
Establishing the cardiotonic steroid ouabain as a potent anti-cancer drug against biliary tract cancer – Step one
Heidemarie, D; Kiesslich, T; Kittl, M; Gaisberger, M; Jakab, M; Mayr, C;
11th ÖGMBT Annual Meeting; 16.-18.9.2019; Salzburg. 2019.
Miniaturization of the Clonogenic Assay Using Confluence Measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
7th Symposium of the Young Physiologists and Pharmacologists; 14.-15.3.2019; Nürnberg. 2019.
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
7th Symposium of the Young Physiologists and Pharmacologists; 14.-15.03.2019; Nürnberg. 2019.

2018

Beiträge in Fachzeitschriften

Glycine Induces Migration of Microglial BV-2 Cells via SNAT-Mediated Cell Swelling.
Kittl, M; Dobias, H; Beyreis, M; Kiesslich, T; Mayr, C; Gaisberger, M; Ritter, M; Kerschbaum, HH; Jakab, M;
Cell Physiol Biochem. 2018; 50(4): 1460-1473.
Originalarbeiten (Zeitschrift)
HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
Klieser, E; Urbas, R; Swierczynski, S; Stättner, S; Primavesi, F; Jäger, T; Mayr, C; Kiesslich, T; Fazio, PD; Helm, K; Neureiter, D;
Int J Mol Sci. 2018; 19(9):
Originalarbeiten (Zeitschrift)
Miniaturization of the Clonogenic Assay Using Confluence Measurement.
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2018; 19(3):
Originalarbeiten (Zeitschrift)
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
Hum Pathol. 2018; 72:117-126
Originalarbeiten (Zeitschrift)
Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer.
Neureiter, D; Kiesslich, T; Ritter, M; Mayr, C;
Expert Opin Ther Targets. 2018; 22(1): 1-3.
Editorials
Single-center implementation of endoscopic submucosal dissection (ESD) in the colorectum: Low recurrence rate after intention-to-treat ESD.
Wagner, A; Neureiter, D; Kiesslich, T; Wolkersdörfer, GW; Pleininger, T; Mayr, C; Dienhart, C; Yahagi, N; Oyama, T; Berr, F;
Dig Endosc. 2018; 30(3):354-363
Originalarbeiten (Zeitschrift)
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
Wanek, J; Gaisberger, M; Beyreis, M; Mayr, C; Helm, K; Primavesi, F; Jäger, T; Di Fazio, P; Jakab, M; Wagner, A; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2018; 19(10):
Originalarbeiten (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Miniaturization of the Clonogenic Assay Using Confluence Measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Evaluation of Napabucasin as a direct inhibitor of cancer stem cells in biliary tract cancer
Beyreis, M; Gaisbberger, M; Helm, K; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Evaluation of Napabucasin as a direct inhibitor of cancer stem cells in biliary tract cancer
Beyreis, M; Gaisberger, M; Helm, K; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T; Mayr, C;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Landrichinger, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Lanrichinger, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Miniaturization of the Clonogenic Assay Using Confluence Measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Isolation and initial characterization of biliary tract cell-derived exosomes
Stangassigner, L; Beyreis, M; Dobias, H; Pichler, M; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
HDAC5 as a novel pharmacological target in pancreatic neuroendocrine tumor cells
Wanek; J; Gaisberger, M; Beyreis, M; Mayr, C; Primnavesi, F; DiFazio, F; Jakab, M; Neureiter, D; Kiesslich, T;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.

2017

Beiträge in Fachzeitschriften

In Vitro Cell Death Discrimination and Screening Method by Simple and Cost-Effective Viability Analysis.
Helm, K; Beyreis, M; Mayr, C; Ritter, M; Jakab, M; Kiesslich, T; Plaetzer, K;
Cell Physiol Biochem. 2017; 41(3): 1011-1019.
Originalarbeiten (Zeitschrift)
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
Kessler, SM; Lederer, E; Laggai, S; Golob-Schwarzl, N; Hosseini, K; Petzold, J; Schweiger, C; Reihs, R; Keil, M; Hoffmann, J; Mayr, C; Kiesslich, T; Pichler, M; Kim, KS; Rhee, H; Park, YN; Lax, S; Obrist, P; Kiemer, AK; Haybaeck, J;
Oncotarget. 2017; 8(52): 89736-89745.
Originalarbeiten (Zeitschrift)
Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
Klieser, E; Urbas, R; Stättner, S; Primavesi, F; Jäger, T; Dinnewitzer, A; Mayr, C; Kiesslich, T; Holzmann, K; Di Fazio, P; Neureiter, D; Swierczynski, S;
Hum Pathol. 2017; 65: 41-52.
Originalarbeiten (Zeitschrift)
Biliary tract cancer stem cells - translational options and challenges.
Mayr, C; Ocker, M; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T;
World J Gastroenterol. 2017; 23(14): 2470-2482.
Übersichtsarbeiten
Reduced complication rates of percutaneous transhepatic biliary drainage with ultrasound guidance.
Wagner, A; Mayr, C; Kiesslich, T; Berr, F; Friesenbichler, P; Wolkersdörfer, GW;
J Clin Ultrasound. 2017; 45(7): 400-407.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

The effect of Napabucasin on cancer stem cells in biliary tract cancer
Beyreis, M; Helm, K; Dobias, H; Jakab, M; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C
ACTA PHYSIOL. 2017; 221: 252-252.
Abstracts (Zeitschrift)
In Vitro Cell Death Discrimination and Screening Method by Simple and Cost-Effective Viability Analysis
Helm, K; Beyreis, M; Mayr, C; Ritter, M; Jakab, M; Kiesslich, T; Platzer, K
ACTA PHYSIOL. 2017; 221: 176-176.
Abstracts (Zeitschrift)
The histone-modification complex G9a and its role in biliary tract cancer/cholangiocarcinoma
Helm, K; Mayr, C; Beyreis, M; Ritter, M; Jakab, M; Klieser, E; Kiesslich, T; Neureiter, D
ACTA PHYSIOL. 2017; 221: 252-252.
Abstracts (Zeitschrift)
Expression pattern of histone deacetylases in gastrointestinal stromal tumors compared to clinic-pathological data
Klieser, E; Schmidt, J; Jäger, T; Mayr, C; Urbas, R; Kiesslich, T; Neureiter, D
Der Pathologe. 2017; 38(Supp. 1):S133-S133.-101. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V.; 22.-24.06.2017; Erlangen.
Abstracts (Zeitschrift)
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in binary tract cancer cells
Mayr, C; Wagner, A; Loffelberger, M; Bruckner, D; Jakab, M; Berr, F; Fazio, P; Ocker, M; Neureiters, D; Pichler, M; Kiesslich, T
ACTA PHYSIOL. 2017; 221: 250-252.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

Krebsstammzellen beim Melanom – von der Definition zur Therapie
Mayr, C; Neureiter, D; Kiesslich, T
JATROS Dermatologie & Plastische Chirurgie. 2017. 1: 10-13.

2016

Beiträge in Fachzeitschriften

Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review.
Klieser, E; Swierczynski, S; Mayr, C; Jäger, T; Schmidt, J; Neureiter, D; Kiesslich, T; Illig, R;
World J Gastrointest Pathophysiol. 2016; 7(2): 199-210.
Übersichtsarbeiten
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Mayr, C; Beyreis, M; Wagner, A; Pichler, M; Neureiter, D; Kiesslich, T;
Biomed Res Int. 2016; 2016:4805270
Übersichtsarbeiten
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Mayr, C; Wagner, A; Loeffelberger, M; Bruckner, D; Jakab, M; Berr, F; Di Fazio, P; Ocker, M; Neureiter, D; Pichler, M; Kiesslich, T;
Oncotarget. 2016; 7(1): 745-758.
Originalarbeiten (Zeitschrift)
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M
INT J MOL SCI. 2016; 17(12): 2011
Originalarbeiten (Zeitschrift)
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Urbas, R; Mayr, C; Klieser, E; Fuereder, J; Bach, D; Stättner, S; Primavesi, F; Jaeger, T; Stanzer, S; Ress, AL; Löffelberger, M; Wagner, A; Berr, F; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2016; 17(12):
Originalarbeiten (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A modified viability assay for simple and cost-effective in vitro determination of cell death modes
Helm, K; Hasenleitner, M; Mayr, C; Beyreis, M; Jakab, M; Neureiter, D; Plaetzer, K; Kiesslich, T;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.
Establishment and validation of a cell-based fluorimetric method for measurement of HDL-based cholesterol efflux capacity from macrophages.
Muehlbacher, S; Kiesslich, T; Mayr, C; Kedenko, L; Paulweber, B;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.
Pre-clinical evaluation of novel specific PRC2 inhibitors as potential experimental therapies in biliary tract cancer
Stangassinger, L; Beyreis, M; Helm, K; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.

2015

Beiträge in Fachzeitschriften

The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression.
Gahr, S; Mayr, C; Kiesslich, T; Illig, R; Neureiter, D; Alinger, B; Ganslmayer, M; Wissniowski, T; Fazio, PD; Montalbano, R; Ficker, JH; Ocker, M; Quint, K;
Int J Oncol. 2015; 47(3):963-970
Originalarbeiten (Zeitschrift)
Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy.
Klieser, E; Swierczynski, S; Mayr, C; Schmidt, J; Neureiter, D; Kiesslich, T; Illig, R;
World J Gastrointest Oncol. 2015; 7(12): 473-483.
Übersichtsarbeiten
Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.
Mayr, C; Neureiter, D; Pichler, M; Berr, F; Wagner, A; Kiesslich, T; Namberger, K;
Mol Med Rep. 2015; 12(2):2247-2252
Originalarbeiten (Zeitschrift)
The role of polycomb repressive complexes in biliary tract cancer.
Mayr, C; Neureiter, D; Wagner, A; Pichler, M; Kiesslich, T;
Expert Opin Ther Targets. 2015; 19(3):363-375
Originalarbeiten (Zeitschrift)
The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr, C; Wagner, A; Neureiter, D; Pichler, M; Jakab, M; Illig, R; Berr, F; Kiesslich, T;
BMC Complement Altern Med. 2015; 15:194
Originalarbeiten (Zeitschrift)
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; DI Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T;
Anticancer Res. 2015; 35(9): 4697-4705.
Originalarbeiten (Zeitschrift)
Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy-Long-Term Outcome of a Phase II Pilot Study.
Wagner, A; Wiedmann, M; Tannapfel, A; Mayr, C; Kiesslich, T; Wolkersdörfer, GW; Berr, F; Hauss, J; Witzigmann, H;
Int J Mol Sci. 2015; 16(11): 26619-26628.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
ACTA PHYSIOL. 2015; 213: 148-148.
Abstracts (Zeitschrift)
DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
ACTA PHYSIOL. 2015; 213: 147-148.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

P190: DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
Mayr, C; Stoecklinger, A; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; DiFazio, P; Ocker, M; Neureiter, D; Kiesslich, T
Acta Physiologica. 2015. 213: 147-148.
Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
Mayr C; Wagner A; Beyreis M; Illig R; Berr F; Pichler M; Di Fazio P; Neureiter D; Kiesslich T
Zeitschrift für Gastroenterologie. 2015. 05/2015: 505-505.
P191: Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; DiFazio, P; Ocker, M; Neureiter, D; Kiesslich, T
Acta Physiologica. 2015. 213: 148-148.
Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells
Mayr C; Wagner A; Neureiter D; Pichler M; Ritter M; Illig R; Berr F; Kiesslich T
Zeitschrift für Gastroenterologie. 2015. 05/2015: 504-505.

2014

Beiträge in Fachzeitschriften

Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
Kiesslich, T; Mayr, C; Wachter, J; Bach, D; Fuereder, J; Wagner, A; Alinger, B; Pichler, M; Di Fazio, P; Ocker, M; Berr, F; Neureiter, D;
Mol Cell Biochem. 2014; 396(1-2):257-268
Originalarbeiten (Zeitschrift)
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Pichler, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2014; 15(11):20134-20157
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

PRC2 inhibition may directly target putative cancer stem cells in biliary tract cancer cell lines.
Mayr, C; Wagner, A; Illig, R; Pichler, M; Berr, F; Neureiter, D; Kiesslich, T;
Pathophysiology and Treatment of Cholangiocarcinoma. 2014; -Falk Workshop; 23.-24.01.2014; Tübingen.
Abstracts (Zeitschrift)
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Neureiter, D; Kiesslich, T;
Abstract Band - Pathophysiology and Treatment of Cholangiocarcinoma. 2014; -Falk Workshop; 23.-24.01.2014; Tübingen.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

KG 164: Epithelial-mesenchymal transition-associated microRNA expression pattern in human biliary tract cancer: a clinical and pathological approach
Ilig, R; Kiesslich, T; Kemmerling, R; Alinger, B; Klieser, E; Berr, F; Neureiter, D
Zeitschrift für Gastroenterologie. 2014. 52: KG164-KG164.
DZNep may directly target putative cancer stem cells in biliary tract cancer cells by inhibition of PRC2
Mayr, C; Wagner, A; Stöcklinger, A; Jakab, M; Illig, R; Pichler, M; Berr, F; Neureiter, D; Kiesslich, T
Zeitschrift für Gastroenterologie. 2014. 52: KG167-KG167.